Usefulness of Platelet Response to Clopidogrel by Point-of-Care Testing to Predict Bleeding Outcomes in Patients Undergoing Percutaneous Coronary Intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study)PATTI, Giuseppe; PASCERI, Vincenzo; VIZZI, Vincenzo et al.The American journal of cardiology. 2011, Vol 107, Num 7, pp 995-1000, issn 0002-9149, 6 p.Article

Short-Term, High-Dose Atorvastatin Pretreatment to Prevent Contrast-Induced Nephropathy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention from the ARMYDA-CIN [Atorvastatin for Reduction of MYocardial Damage during Angioplasty―Contrast-Induced Nephropathy] TrialPATTI, Giuseppe; RICOTTINI, Elisabetta; NUSCA, Annunziata et al.The American journal of cardiology. 2011, Vol 108, Num 1, pp 1-7, issn 0002-9149, 7 p.Article

Strategies of Clopidogrel Load and Atorvastatin Reload to Prevent Ischemic Cerebral Events in Patients Undergoing Protected Carotid Stenting: Results of the Randomized ARMYDA-9 CAROTID (Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting) StudyPATTI, Giuseppe; TOMAI, Fabrizio; DI SCIASCIO, Germano et al.Journal of the American College of Cardiology. 2013, Vol 61, Num 13, pp 1379-1387, issn 0735-1097, 9 p.Article

Comparison of Platelet Reactivity and Periprocedural Outcomes in Patients With Versus Without Diabetes Mellitus and Treated With Clopidogrel and Percutaneous Coronary InterventionMANGIACAPRA, Fabio; PATTI, Giuseppe; PEACE, Aaron et al.The American journal of cardiology. 2010, Vol 106, Num 5, pp 619-623, issn 0002-9149, 5 p.Article